You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 7, July 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Controversies in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Cerebrovascular Disease
 •Cardiovascular System
 •Evidence-Based Medicine
 •Prognosis/ Outcomes
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Anticoagulation in Cerebral Venous Sinus Thrombosis

Are We Treating Ourselves?

Mohammad Wasay, MD, FRCP, FAAN; Ayeesha Kamran Kamal, MD, FAHA

Arch Neurol. 2008;65(7):985-987.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

There are a lot of things we know for a fact that simply aren't so.
—Kevin J. McGowan

Cerebral venous sinus thrombosis (CVST) is known for its diverse clinical manifestations and unpredictable outcome. Early autopsy data suggest that it is uniformly fatal. However, the International Study on Cerebral Vein and Dural Sinus Thrombosis data show that 8% of patients with CVST died, mainly due to transtentorial herniation, unilateral focal mass effect, or diffuse edema and multiple parenchymal lesions.1

Independent predictors of death due to CVST include coma, age older than 37 years, deep CVST, right intracerebral hemorrhage and posterior fossa lesion, worsening of previous focal deficits or de novo focal deficits, hemorrhage on admission computed tomography, central nervous system infection, and cancer.1 In this cohort of 624 patients, 57% had modified Rankin scores of 0 at 16 months' follow-up, . . . [Full Text of this Article]

AUTHOR INFORMATION

Author Affiliations: Department of Neurology, The Aga Khan University, Karachi, Pakistan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Sinus Thrombosis Should Be Treated With Anticoagulation
J. Stam
Arch Neurol. 2008;65(7):984-985.
EXTRACT | FULL TEXT  

Cerebral Venous Sinus Thrombosis: To Treat or Not to Treat?
E. S. Roach
Arch Neurol. 2008;65(7):987-988.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cerebral venous sinus thrombosis: a case series including thrombolysis
Mallick et al.
Arch. Dis. Child. 2009;94:790-794.
ABSTRACT | FULL TEXT  

Cerebral Venous Sinus Thrombosis: To Treat or Not to Treat?
Roach
Arch Neurol 2008;65:987-988.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.